I'm more interested in a GNBT/NGIO S1 update , funding, valuation, ALTUCELL status, Q3 filing and listing estimate. As stated in 8k potential vaccine.....lets get some real news and not turn Covid into a smoke screen for current conditions!! If BARDA is approved it will fund the research and not company future plans. I think Auctus court case dated May 23rd is not a good indication of positive news. Are all bets on Covid to clear poor performance and missed PR estimates 2019/20 so far or good news around the corner???? No Covid collaboration with big pharma is somewhat concerning ............any positive update with company listed will have more impact to pps and valuation then excuse to move forward until Covid news............